UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1180-1193

2014

Volltextzugriff (PDF)

MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis

Liver international, 2006-03, Vol.26 (2), p.269-270

2006

Volltextzugriff (PDF)

Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?

Hepatology (Baltimore, Md.), 2001-02, Vol.33 (2), p.333-338

2001

Volltextzugriff (PDF)

Familial clustering of HCV-related liver cirrhosis and hepatocellular carcinoma

Digestive and liver disease, 2005-09, Vol.37 (9), p.716-717

2005

Volltextzugriff (PDF)

C4BQ0: a genetic marker of familial HCV-related liver cirrhosis

Digestive and liver disease, 2004-07, Vol.36 (7), p.471-477

2004

Volltextzugriff (PDF)

Portal hypertension : diagnosis and treatment

Journal of hepatology, 1995, Vol.23, p.36-44

1995

Volltextzugriff (PDF)

Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients: Final report of a multicenter randomized trial

Journal of hepatology, 1989, Vol.9 (1), p.75-83

The Italian Multicenter Project for Propranolol in Prevention of Bleeding

1989

Volltextzugriff (PDF)

Second study shows that octreotide may prevent early rebleeding in cirrhosis [letter]

BMJ. British medical journal (International ed.), 1998-04, Vol.316 (7140), p.1320

International edition, 1998

Volltextzugriff (PDF)

Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal Varices: An Analysis of Data and Prognostic Factors in 589 Patients from Four Randomized Clinical Trials

The New England journal of medicine, 1991-05, Vol.324 (22), p.1532-1538

1991

Volltextzugriff (PDF)

Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial

Hepatology (Baltimore, Md.), 1998-11, Vol.28 (5), p.1206-1214

1998

Volltextzugriff (PDF)

Familial clustering of (mostly) HCV-related cirrhosis. A case-control study

Journal of hepatology, 2002-12, Vol.37 (6), p.762-766

2002

Volltextzugriff (PDF)

Inherited coagulation disorder in hepatic vein and portal vein thrombosis

Journal of hepatology, 2003-04, Vol.38, p.213-213

2003

Volltextzugriff (PDF)

Second study shows that octreotide may prevent early rebleeding in cirrhosis

BMJ, 1998-04, Vol.316 (7140), p.1320-1320

1998

Volltextzugriff (PDF)

566 MTHFR C677T as genetic risk factor in young adults with cryptogenic cirrhosis and portal vein thrombosis

Journal of hepatology, 2004, Vol.40, p.166-166

2004

Volltextzugriff (PDF)

The incidence of esophageal varices in cirrhosis

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A2-A2

2001

Volltextzugriff (PDF)

The incidence esophageal varices in cirrhosis

Journal of hepatology, 2001-04, Vol.34, p.71-72

2001

Volltextzugriff (PDF)

Isosorbide monitrate with nadolol campared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double blind placebo controlled randomized trial. Final report

Journal of hepatology, 2001-04, Vol.34, p.63-63

2001

Volltextzugriff (PDF)

Familial risk of liver cirrhosis (LC) and hepatocellular carcinoma (HCC) among HCV patients

Journal of hepatology, 2001-04, Vol.34, p.99-99

2001

Volltextzugriff (PDF)

Prognostic indicators in cirrhosis: the role of child classification. Overview of 56 published studies and validation in a prospective cohort of patients

Journal of hepatology, 2001-04, Vol.34, p.59-59

2001

Volltextzugriff (PDF)

Prognostic indicators in cirrhosis: The role of child classification. Overview of 56 published studies and validation in a prospective cohort of patients

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A370-A371

2001

Volltextzugriff (PDF)

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis : a randomized clinical trial

Journal of hepatology, 1994-02, Vol.20 (2), p.206-212

1994

Volltextzugriff (PDF)

Which patients with cirrhosis should undergo endoscopic screening for esophageal varices (EV) detection?

Journal of hepatology, 2001-04, Vol.34, p.64-65

2001

Volltextzugriff (PDF)

Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial

Hepatology (Baltimore, Md.), 1988-01, Vol.8 (1), p.1-5

1988

Volltextzugriff (PDF)

A randomised controlled trial of propranolol for the prevention of initial bleeding in cirrhotic patients with portal hypertension. Preliminary results. The Italian Multicenter Project for Propranolol in the Prevention of Bleeding

Drugs (New York, N.Y.), 1989, Vol.37 Suppl 2, p.48-51; discussion 74-6

1989

Volltextzugriff (PDF)

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital

Journal of hepatology, 1994-02, Vol.20 (2), p.206

1994

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(205)

Publikationsform

Artikel
(235)
Tagungsberichte
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients

MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis

Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?

Familial clustering of HCV-related liver cirrhosis and hepatocellular carcinoma

C4BQ0: a genetic marker of familial HCV-related liver cirrhosis

Portal hypertension : diagnosis and treatment

Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients: Final report of a multicenter randomized trial

Second study shows that octreotide may prevent early rebleeding in cirrhosis [letter]

Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal Varices: An Analysis of Data and Prognostic Factors in 589 Patients from Four Randomized Clinical Trials

Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial

Familial clustering of (mostly) HCV-related cirrhosis. A case-control study

Inherited coagulation disorder in hepatic vein and portal vein thrombosis

Second study shows that octreotide may prevent early rebleeding in cirrhosis

566 MTHFR C677T as genetic risk factor in young adults with cryptogenic cirrhosis and portal vein thrombosis

The incidence of esophageal varices in cirrhosis

The incidence esophageal varices in cirrhosis

Isosorbide monitrate with nadolol campared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double blind placebo controlled randomized trial. Final report

Familial risk of liver cirrhosis (LC) and hepatocellular carcinoma (HCC) among HCV patients

Prognostic indicators in cirrhosis: the role of child classification. Overview of 56 published studies and validation in a prospective cohort of patients

Prognostic indicators in cirrhosis: The role of child classification. Overview of 56 published studies and validation in a prospective cohort of patients

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis : a randomized clinical trial

Which patients with cirrhosis should undergo endoscopic screening for esophageal varices (EV) detection?

Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial

A randomised controlled trial of propranolol for the prevention of initial bleeding in cirrhotic patients with portal hypertension. Preliminary results. The Italian Multicenter Project for Propranolol in the Prevention of Bleeding

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital

Aktive Filter

Suchergebnisse filtern